Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma

americanpharmaceuticalreviewAugust 23, 2018

Tag: FDA , Agilent , urothelial carcinoma

PharmaSources Customer Service